Crossref
N 6 ‑methyladenosine reader IGF2BP3 promotes endometrial cancer progression via modification of circ‑EPB41L2 expression
Oncology Letters · 03.11.2026 · 33 (1) · 1-10
DOI: 10.3892/ol.2026.15937 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 03.11.2026. Verfasst von Liping Lai und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lai, L., Feng, X., Zheng, Y., & Shu, S. (2026). N 6 ‑methyladenosine reader IGF2BP3 promotes endometrial cancer progression via modification of circ‑EPB41L2 expression. Oncology Letters, 33(1), 1-10. https://doi.org/10.3892/ol.2026.15937
Vancouver
Lai L, Feng X, Zheng Y, Shu S. N 6 ‑methyladenosine reader IGF2BP3 promotes endometrial cancer progression via modification of circ‑EPB41L2 expression. Oncology Letters. 2026;33(1):1-10. doi:10.3892/ol.2026.15937
BibTeX
@article{Lai2026,
author = {Lai, Liping and Feng, Xiaoxiao and Zheng, Yiting and Shu, Shanrong},
title = {N 6 ‑methyladenosine reader IGF2BP3 promotes endometrial cancer progression via modification of circ‑EPB41L2 expression},
journal = {Oncology Letters},
year = {2026},
volume = {33},
number = {1},
pages = {1--10},
doi = {10.3892/ol.2026.15937}
}
EUVIMED